BioNexus Gene Lab Corp. Other Receivables
BioNexus Gene Lab Corp. (BGLC) had Other Receivables of $235.73 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › and Others › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2025-05-15
- 2025-03-31: Other Receivables $235.73K.
- 2024-12-31: Other Receivables $203.66K.
- 2024-09-30: Other Receivables $65.68K.
- 2024-06-30: Other Receivables $400.83K.
| Period end | Other Receivables |
|---|---|
| 2025-03-31 | $235.73K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $203.66K 10-Q · filed 2025-05-15 |
| 2024-09-30 | $65.68K 10-Q · filed 2024-11-15 |
| 2024-06-30 | $400.83K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $106.30K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $122.43K 10-K · filed 2025-04-15 |
| 2023-09-30 | $110.79K 10-Q/A · filed 2024-03-26 |
| 2023-06-30 | $47.48K 10-Q · filed 2023-08-16 |
| 2023-03-31 | $29.35K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $25.24K 10-K · filed 2024-04-16 |
| 2022-09-30 | $72.60K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $81.59K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $71.53K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $79.52K 10-K · filed 2023-03-31 |
| 2021-09-30 | $23.43K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $29.36K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $22.93K 10-Q · filed 2021-05-18 |
| 2020-12-31 | $22.64K 10-K · filed 2022-04-06 |
| 2020-09-30 | $13.85K 10-Q/A · filed 2020-11-09 |
| 2020-06-30 | $13.17K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $13.93K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $13.06K 10-K · filed 2021-03-30 |
| 2019-09-30 | $26.69K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $24.45K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $26.78K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $22.81K 10-K · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |